237 related articles for article (PubMed ID: 11136928)
1. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke.
Di Napoli M; Papa F; Bocola V
Stroke; 2001 Jan; 32(1):133-8. PubMed ID: 11136928
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke.
Winbeck K; Poppert H; Etgen T; Conrad B; Sander D
Stroke; 2002 Oct; 33(10):2459-64. PubMed ID: 12364738
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein in ischemic stroke: an independent prognostic factor.
Di Napoli M; Papa F; Bocola V
Stroke; 2001 Apr; 32(4):917-24. PubMed ID: 11283392
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients.
Di Napoli M; Papa F;
Stroke; 2002 Jul; 33(7):1763-71. PubMed ID: 12105349
[TBL] [Abstract][Full Text] [Related]
5. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke.
Weir CJ; Muir SW; Walters MR; Lees KR
Stroke; 2003 Aug; 34(8):1951-6. PubMed ID: 12843346
[TBL] [Abstract][Full Text] [Related]
6. C-Reactive Protein and T3: New Prognostic Factors in Acute Ischemic Stroke.
Irimie CA; Vârciu M; Irimie M; Ifteni PI; Minea DI
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2731-2737. PubMed ID: 30056003
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome.
Rajeshwar K; Kaul S; Al-Hazzani A; Babu MS; Balakrishna N; Sharma V; Jyothy A; Munshi A
Inflammation; 2012 Jun; 35(3):978-84. PubMed ID: 22038116
[TBL] [Abstract][Full Text] [Related]
8. The role of high-sensitivity C-reactive protein levels in functional outcomes in patients with large-artery atherosclerosis and small-artery occlusion.
Hou D; Liu J; Feng R; Gao Y; Wang Y; Wu J
Neurol Res; 2017 Nov; 39(11):981-987. PubMed ID: 28749740
[TBL] [Abstract][Full Text] [Related]
9. Elevated Serum High-Mobility Group Box-1 Protein Level Is Associated with Poor Functional Outcome in Ischemic Stroke.
Tsukagawa T; Katsumata R; Fujita M; Yasui K; Akhoon C; Ono K; Dohi K; Aruga T
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2404-2411. PubMed ID: 28645523
[TBL] [Abstract][Full Text] [Related]
10. Combination of High-Sensitivity C-Reactive Protein and Homocysteine Predicts the Post-Stroke Depression in Patients with Ischemic Stroke.
Cheng LS; Tu WJ; Shen Y; Zhang LJ; Ji K
Mol Neurobiol; 2018 Apr; 55(4):2952-2958. PubMed ID: 28456936
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory cytokines and early neurological worsening in ischemic stroke.
Vila N; Castillo J; Dávalos A; Chamorro A
Stroke; 2000 Oct; 31(10):2325-9. PubMed ID: 11022058
[TBL] [Abstract][Full Text] [Related]
12. Association of circulating high-sensitivity C-reactive protein with late recurrence after ischemic stroke.
Zhang YB; Yin Z; Han X; Wang Q; Zhang Z; Geng J
Neuroreport; 2017 Jul; 28(10):598-603. PubMed ID: 28542069
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and fibrinogen in acute stroke patients with and without sleep apnea.
Dziewas R; Ritter M; Kruger L; Berger S; Langer C; Kraus J; Dittrich R; Schabitz WR; Ringelstein EB; Young P
Cerebrovasc Dis; 2007; 24(5):412-7. PubMed ID: 17878721
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members.
Di Napoli M; Schwaninger M; Cappelli R; Ceccarelli E; Di Gianfilippo G; Donati C; Emsley HC; Forconi S; Hopkins SJ; Masotti L; Muir KW; Paciucci A; Papa F; Roncacci S; Sander D; Sander K; Smith CJ; Stefanini A; Weber D
Stroke; 2005 Jun; 36(6):1316-29. PubMed ID: 15879341
[TBL] [Abstract][Full Text] [Related]
15. The role of high high-sensitivity C-reactive protein levels at admission on poor prognosis after acute ischemic stroke.
Cai Z; He W; Zhuang FJ; Chen Y
Int J Neurosci; 2019 May; 129(5):423-429. PubMed ID: 30332913
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke.
Di Napoli M; Papa F
Stroke; 2003 Dec; 34(12):2922-9. PubMed ID: 14605324
[TBL] [Abstract][Full Text] [Related]
17. Predictors of occult cancer in acute ischemic stroke patients.
Cocho D; Gendre J; Boltes A; Espinosa J; Ricciardi AC; Pons J; Jimenez M; Otermin P
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1324-8. PubMed ID: 25881772
[TBL] [Abstract][Full Text] [Related]
18. Can Prediction of Functional Outcome after Stroke Be Improved by Adding Fibrinogen to Prognostic Model?
Swarowska M; Ferens A; Pera J; Slowik A; Dziedzic T
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2752-2755. PubMed ID: 27503272
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients.
Naess H; Nyland H; Idicula T; Waje-Andreassen U
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e435-40. PubMed ID: 23735372
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke.
Li YM; Liu XY
J Neurol Sci; 2015 May; 352(1-2):68-73. PubMed ID: 25868898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
